title: Percutaneous Cryoablation for Liver Cancer.
abstract: Based on the primary tumor site, liver cancer can be divided into two categories: (1) primary liver cancer and (2) metastatic cancer to the liver from a distant primary site. Guided cryoablation via many imaging methods induces iceball formation and tumor necrosisand is an attractive option for treating unresectable hepatocellular carcinoma (HCC) and metastatic liver cancer. There are several advantages to using cryoablation for the treatment of liver cancer: it can be performed percutaneously, intraoperatively, and laparoscopically; iceball formation can be monitored; it has little impact on nearby large blood vessels; and it induces a cryo-immunological response in situ. Clinically, primary research has shown that percutaneous cryoablation of liver cancer is relatively safe and efficient, and it can be combined with other methods, such as radiation therapy, chemotherapy, and immunology, to control disease. Although research is preliminary, cryosurgery is fast becoming an alternative treatment method for HCC or liver tumors. Here, we review the mechanisms of liver tumor cryoablation, cryoablation program selection, clinical efficiency, and complications following treatment.
authors.affiliation: Fuda Cancer Hospital, Jinan University School of Medicine, Tianhe District, Guangzhou, China ; Guangzhou Fuda Cancer Institute, Tianhe District, Guangzhou, China.
authors.forename: Li-Zhi
authors.initials: LZ
authors.lastname: Niu
authors.affiliation: Guangzhou Fuda Cancer Institute, Tianhe District, Guangzhou, China.
authors.forename: Jia-Liang
authors.initials: JL
authors.lastname: Li
authors.affiliation: Fuda Cancer Hospital, Jinan University School of Medicine, Tianhe District, Guangzhou, China ; Guangzhou Fuda Cancer Institute, Tianhe District, Guangzhou, China.
authors.forename: Ke-Cheng
authors.initials: KC
authors.lastname: Xu
keywords: Cryosurgery; Efficacy; Hepatocellular carcinoma; Metastatic disease